Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Total Non-Current Liabilities: 2022-2024

Historic Total Non-Current Liabilities for Orchestra BioMed Holdings (OBIO) over the last 2 years, with Dec 2024 value amounting to $43.2 million.

  • Orchestra BioMed Holdings' Total Non-Current Liabilities was N/A to $60.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $60.8 million, marking a year-over-year change of. This contributed to the annual value of $43.2 million for FY2024, which is N/A change from last year.
  • Per Orchestra BioMed Holdings' latest filing, its Total Non-Current Liabilities stood at $43.2 million for FY2024, which was up 5.44% from $40.9 million recorded in FY2022.
  • In the past 5 years, Orchestra BioMed Holdings' Total Non-Current Liabilities ranged from a high of $43.2 million in FY2024 and a low of $40.9 million during FY2022.
  • For the 2-year period, Orchestra BioMed Holdings' Total Non-Current Liabilities averaged around $42.1 million, with its median value being $42.1 million (2022).